4J Therapeutics, Inc. is a preclinical biopharmaceutical company focused on the development of novel, broad-spectrum antiviral agents for the treatment of influenza and other serious viral infections using a unique programmable antiviral platform approach. Our strategy employs the rapid identification of essential RNA motifs encoded in the genome of viruses of public health concern, and targeting them with a new class of potent, programmable, and globally deployable antiviral therapeutics. Our preclinical pipeline consists of new chemical entities targeting influenza A virus and other viruses of major medical importance and pandemic potential.
Company Details
4j Therapeutics, Inc. Questions
4J Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/4j-therapeutics
4J Therapeutics, Inc. has
1 employees.
View email and phone details for 1
employees at 4J Therapeutics, Inc..
4J Therapeutics, Inc.'s industry is
Biotechnology Research
4J Therapeutics, Inc.'s top competitors are
Bighat Biosciences,
Greenstone Biosciences,
Orsobio,
Epibiologics,
Fairfield Labs,
Inograft Biotherapeutics, Inc.,
Adicet Bio, Inc,
Dren Bio, Inc.,
Turn Biotechnologies,
Nextvivo.
4J Therapeutics, Inc.'s categories are Biotechnology Research
